VANC Announces Agreement for Acquisition of Corozon Platform

VANC Pharmaceuticals (TSXV:VANC) (OTCQB:NUVPF) is pleased to announce it has entered into a defintive agreement with Corozon Consulting Corporation for the acquisition of the Corozon Platform. The Platform is an innovative portal designed to provide front line community pharmacists with the knowledge and tools to implement practice change and enhance their professional service programs.

As quoted in the press release:

The Platform itself consists of two complementary modules. ‘Corozon Academy’ offers practical professional education for community pharmacists. The Academy uses short video vignettes hosted by experts in different therapeutic areas to teach pharmacists how to implement, operationalize, and monetize unique clinical services. ‘Corozon Hardware’ is an e-commerce portal that allows pharmacists to order point-of-care diagnostic devices and supplies. Through these two modules the Platform provides easy access to the latest point-of-care diagnostic devices and also extensive information on how to implement these devices into daily pharmacy practice.

“The unique clinical programs, easy to navigate site, and ready to use tools have quickly made the Corozon Platform the go to site for pharmacists looking to change their practice” says Bryan Gray, managing partner of Corozon Consulting. “The platform aligns well with VANC Pharmaceuticals’ new strategic direction.”

Click here to read the full press release.